A group of bipartisan lawmakers is intensifying efforts to reform the health care industry by proposing legislation aimed at breaking up large health care conglomerates, particularly focusing on pharmacy benefit managers (PBMs) and health insurers. This initiative comes amid declining stock prices for major health care companies as news of potential regulatory changes circulates. Lawmakers, including Senators Warren and Hawley, are specifically advocating for the forced divestment of pharmacies from these companies to combat rising prescription drug costs. The push has garnered attention as lawmakers examine the role PBMs play in inflating drug prices and impacting patient access to affordable medications. As these legislative efforts unfold, experts are debating the likelihood of success and its implications for the overall health care landscape.